Literature DB >> 8676467

Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype.

R B Ray1, L M Lagging, K Meyer, R Ray.   

Abstract

We have previously demonstrated that hepatitis C virus (HCV) core protein regulates cellular protooncogenes at the transcriptional level; this observation implicates core protein in the alteration of normal hepatocyte growth. In the present study, the transforming potential of the HCV core gene was investigated by using primary rat embryo fibroblast (REF) cells which were transfected with or without cooperative oncogenes. Integration of the HCV core gene resulted in expression of the viral protein in REF stable transformants. REF cells cotransfected with HCV core and H-ras genes became transformed and exhibited rapid proliferation, anchor-independent growth, and tumor formation in athymic nude mice. Results from these studies suggest that the core protein plays an important role in the regulation of HCV-infected cell growth and in the transformation to tumorigenic phenotype. These observations suggest a possible mechanism for this viral protein in the pathogenesis of hepatocellular carcinoma in HCV-infected humans.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8676467      PMCID: PMC190377     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Persistence of HCV despite antibodies to both putative envelope glycoproteins.

Authors:  D Y Chien; Q L Choo; R Ralston; R Spaete; M Tong; M Houghton; G Kuo
Journal:  Lancet       Date:  1993-10-09       Impact factor: 79.321

2.  The E6 gene of human papillomavirus type 16 is sufficient for transformation of baby rat kidney cells in cotransfection with activated Ha-ras.

Authors:  Z Liu; J Ghai; R S Ostrow; R C McGlennen; A J Faras
Journal:  Virology       Date:  1994-06       Impact factor: 3.616

3.  Biosynthesis and biochemical properties of the hepatitis C virus core protein.

Authors:  E Santolini; G Migliaccio; N La Monica
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

4.  Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus.

Authors:  R Ray; A Khanna; L M Lagging; K Meyer; Q L Choo; R Ralston; M Houghton; P R Becherer
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

5.  Tumours of the liver.

Authors:  M C Kew
Journal:  Scand J Gastroenterol Suppl       Date:  1992

6.  Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells.

Authors:  C M Shih; S J Lo; T Miyamura; S Y Chen; Y H Lee
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

7.  Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome.

Authors:  M J Selby; Q L Choo; K Berger; G Kuo; E Glazer; M Eckart; C Lee; D Chien; C Kuo; M Houghton
Journal:  J Gen Virol       Date:  1993-06       Impact factor: 3.891

Review 8.  Cellular and molecular mechanisms of hepatocarcinogenesis.

Authors:  C E Rogler; F V Chisari
Journal:  Semin Liver Dis       Date:  1992-08       Impact factor: 6.115

9.  p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis.

Authors:  T Teramoto; K Satonaka; S Kitazawa; T Fujimori; K Hayashi; S Maeda
Journal:  Cancer Res       Date:  1994-01-01       Impact factor: 12.701

10.  Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes.

Authors:  R J Jewers; P Hildebrandt; J W Ludlow; B Kell; D J McCance
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

View more
  76 in total

1.  A transgenic mouse model of steatosis and hepatocellular carcinoma associated with chronic hepatitis C virus infection in humans.

Authors:  S M Lemon; H Lerat; S A Weinman; M Honda
Journal:  Trans Am Clin Climatol Assoc       Date:  2000

2.  Molecular biology of liver disorders:the hepatitis C virus and molecular targets for drug development.

Authors:  Howard J Worman; Feng Lin
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

3.  Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection.

Authors:  H Huang; H Fujii; A Sankila; B M Mahler-Araujo; M Matsuda; G Cathomas; H Ohgaki
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

4.  Molecular determinants for subcellular localization of hepatitis C virus core protein.

Authors:  Ryosuke Suzuki; Shinichiro Sakamoto; Takeya Tsutsumi; Akiko Rikimaru; Keiko Tanaka; Takashi Shimoike; Kohji Moriishi; Takuya Iwasaki; Kiyohisa Mizumoto; Yoshiharu Matsuura; Tatsuo Miyamura; Tetsuro Suzuki
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 5.  Virion factors that target Daxx to overcome intrinsic immunity.

Authors:  Sabrina Schreiner; Harald Wodrich
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

6.  Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma.

Authors:  C Rabe; T Pilz; C Klostermann; M Berna; H H Schild; T Sauerbruch; W H Caselmann
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

Review 7.  Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.

Authors:  Jinah Choi; Nicole L B Corder; Bhargav Koduru; Yiyan Wang
Journal:  Free Radic Biol Med       Date:  2014-05-06       Impact factor: 7.376

Review 8.  The hepatitis C virus persistence: how to evade the immune system?

Authors:  Nicole Pavio; Michael M C Lai
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

9.  The native form and maturation process of hepatitis C virus core protein.

Authors:  K Yasui; T Wakita; K Tsukiyama-Kohara; S I Funahashi; M Ichikawa; T Kajita; D Moradpour; J R Wands; M Kohara
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Modulation of retinoid signaling by a cytoplasmic viral protein via sequestration of Sp110b, a potent transcriptional corepressor of retinoic acid receptor, from the nucleus.

Authors:  Koichi Watashi; Makoto Hijikata; Ayako Tagawa; Takahiro Doi; Hiroyuki Marusawa; Kunitada Shimotohno
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.